UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Fresh Tracks Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.01

(Title of Class of Securities)

10802T204

(CUSIP Number)

January 17, 2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐

Rule 13d-1(b)

☒

Rule 13d-1(c)

☐

Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 10802T204

(1)	Name of Reporting Person Exploration Capital, LLC
(2)	Check the Appropriate Box if a Member of a Group
	(a) ☐
	(b) ☐

(3)	SEC Use Only

(4)	Citizenship or Place of Organization Delaware

Number of
shares
beneficially
owned by
each
reporting
person with:

(5)

Sole Voting Power

None

(6)

Shared Voting Power

850,000

(7)

Sole Dispositive Power

None

(8)

Shared Dispositive Power

850,000


(9)	Aggregate Amount Beneficially Owned by Each Reporting Person

	850,000

(10)	Check if the Aggregate Amount in Row (9) Excludes Certain Shares

	Not Applicable.

(11)	Percent of Class Represented by Amount in Row (9)

	14.2%
(12)	Type of Reporting Person OO

CUSIP No. 10802T204

(1)	Name of Reporting Person Stephen L. Gustin
(2)	Check the Appropriate Box if a Member of a Group
	(a) ☐
	(b) ☐

(3)	SEC Use Only

(4)	Citizenship or Place of Organization United States

Number of
shares
beneficially
owned by
each
reporting
person with:

(5)

Sole Voting Power

47,000

(6)

Shared Voting Power

850,000

(7)

Sole Dispositive Power

47,000

(8)

Shared Dispositive Power

850,000


(9)	Aggregate Amount Beneficially Owned by Each Reporting Person

	897,000

(10)	Check if the Aggregate Amount in Row (9) Excludes Certain Shares

	Not Applicable.

(11)	Percent of Class Represented by Amount in Row (9)

	15.0%
(12)	Type of Reporting Person IN

ITEM 1(A) NAME OF ISSUER:

Fresh Tracks Therapeutics, Inc.

ITEM 1(B) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

2000 Central Avenue

Boulder, CO 80301

ITEM 2 (A) NAME OF PERSON FILING:

Exploration Capital, LLC

Stephen L. Gustin

ITEM 2 (B) ADDRESS OR PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

250 East 200 South, Floor 16

Salt Lake City, UT 84111

ITEM 2 (C) CITIZENSHIP:

Exploration Capital, LLC – Delaware

Stephen L. Gustin – United States

ITEM 2 (D) TITLE OF CLASS OF SECURITIES:

Common Stock, $0.01 par value per share

ITEM 2 (E) CUSIP Number:

10802T204

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO §§ 240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:

This statement is filed pursuant to Rule 13d-1(c).

ITEM 4. OWNERSHIP

See the Cover Pages for each Reporting Person.

ITEM 5. OWNERSHIP OF 5 PERCENT OR LESS OF A CLASS

Not Applicable.

ITEM 6. OWNERSHIP OF MORE THAN 5 PERCENT ON BEHALF OF ANOTHER PERSON

Not Applicable.

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON

Not Applicable.

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

Not Applicable.

ITEM 9. NOTICE OF DISSOLUTION OF GROUP

Not Applicable.

ITEM 10. CERTIFICATIONS

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.

	Dated:	01/17/2024

	Exploration Capital, LLC

	Signature.	/s/ Stephen L. Gustin
		Stephen L. Gustin
		Managing Partner

	Stephen L. Gustin

	Signature.	/s/ Stephen L. Gustin
		Stephen L. Gustin

Fresh Tracks Therapeutics, Inc. SC 13G/A